HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 299 filers reported holding HAEMONETICS CORP in Q4 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,604,794 | -9.7% | 43,573 | -6.9% | 0.02% | -5.0% |
Q1 2024 | $3,992,588 | -14.7% | 46,779 | -14.5% | 0.02% | -23.1% |
Q4 2023 | $4,680,732 | -13.1% | 54,739 | -9.0% | 0.03% | -21.2% |
Q3 2023 | $5,388,416 | +14.7% | 60,152 | +9.0% | 0.03% | +13.8% |
Q2 2023 | $4,699,302 | -7.9% | 55,195 | -10.4% | 0.03% | -6.5% |
Q1 2023 | $5,099,800 | +8.9% | 61,629 | +3.5% | 0.03% | +19.2% |
Q4 2022 | $4,681,799 | -21.9% | 59,527 | -26.5% | 0.03% | -13.3% |
Q3 2022 | $5,995,000 | +13.5% | 80,981 | -0.1% | 0.03% | +36.4% |
Q2 2022 | $5,283,000 | +13.7% | 81,045 | +10.3% | 0.02% | +15.8% |
Q1 2022 | $4,646,000 | +56.5% | 73,493 | +31.3% | 0.02% | +11.8% |
Q4 2021 | $2,969,000 | -11.8% | 55,975 | +17.4% | 0.02% | -5.6% |
Q3 2021 | $3,365,000 | -2.7% | 47,669 | -8.2% | 0.02% | -18.2% |
Q2 2021 | $3,459,000 | – | 51,905 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bridge City Capital, LLC | 40,541 | $5,114,000 | 2.20% |
Lisanti Capital Growth, LLC | 53,385 | $6,734,000 | 2.20% |
Nitorum Capital, L.P. | 279,510 | $35,257,000 | 2.05% |
CROWN ADVISORS MANAGEMENT, INC. | 20,000 | $2,523,000 | 1.69% |
Millrace Asset Group, Inc. | 11,400 | $1,438,000 | 1.69% |
COOKSON PEIRCE & CO INC | 145,884 | $18,402,000 | 1.61% |
Endurant Capital Management LP | 32,594 | $4,111,000 | 1.48% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 111,000 | $14,002,000 | 1.38% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 110,065 | $13,884,000 | 1.37% |
EMERALD ADVISERS, LLC | 203,640 | $25,687,000 | 1.20% |